Log In
BCIQ
Print this Print this
 

MFE-23

  Manage Alerts
Collapse Summary General Information
Company Cancer Research Technology Ltd.
DescriptionSingle chain Fv mAb against carcinoembryonic antigen (CEA)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsAutologous T cell therapy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today